Victory Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$82.2K Buy
17,608
+484
+3% +$2.26K ﹤0.01% 2346
2025
Q1
$94K Sell
17,124
-361
-2% -$1.98K ﹤0.01% 2315
2024
Q4
$59.3K Sell
17,485
-33
-0.2% -$112 ﹤0.01% 2374
2024
Q3
$49.9K Sell
17,518
-366
-2% -$1.04K ﹤0.01% 2393
2024
Q2
$40.2K Buy
17,884
+529
+3% +$1.19K ﹤0.01% 2387
2024
Q1
$38.4K Sell
17,355
-99
-0.6% -$219 ﹤0.01% 2397
2023
Q4
$41K Buy
17,454
+3,343
+24% +$7.86K ﹤0.01% 2456
2023
Q3
$26.2K Buy
14,111
+413
+3% +$768 ﹤0.01% 2434
2023
Q2
$35.9K Sell
13,698
-319
-2% -$836 ﹤0.01% 2418
2023
Q1
$22.8K Sell
14,017
-487
-3% -$794 ﹤0.01% 2501
2022
Q4
$19.3K Sell
14,504
-6
-0% -$8 ﹤0.01% 2513
2022
Q3
$23K Sell
14,510
-2,245
-13% -$3.56K ﹤0.01% 2617
2022
Q2
$26K Sell
16,755
-62
-0.4% -$96 ﹤0.01% 2597
2022
Q1
$41K Buy
16,817
+852
+5% +$2.08K ﹤0.01% 2610
2021
Q4
$47K Buy
+15,965
New +$47K ﹤0.01% 2648
2021
Q2
Sell
-10,236
Closed -$46K 2815
2021
Q1
$46K Buy
+10,236
New +$46K ﹤0.01% 2673
2020
Q2
Sell
-10,912
Closed -$22K 3306
2020
Q1
$22K Buy
+10,912
New +$22K ﹤0.01% 3065
2019
Q4
Sell
-3,105
Closed -$31K 3298
2019
Q3
$31K Buy
+3,105
New +$31K ﹤0.01% 2894
2019
Q2
Sell
-3,454
Closed -$35K 1864
2019
Q1
$35K Hold
3,454
﹤0.01% 1727
2018
Q4
$59K Hold
3,454
﹤0.01% 1680
2018
Q3
$61K Buy
3,454
+454
+15% +$8.02K ﹤0.01% 1709
2018
Q2
$57K Buy
+3,000
New +$57K ﹤0.01% 1749